3558 results for «328»
3558 results
New devices for aortic intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.
Rapid-fire - Outcome studies after valvular intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
This session of rapid-fire submitted cases focuses on outcome studies after valvular intervention. Learn about clinical impacts of cerebral micro-bleeds in patients undergoing TAVI, explore the long-term outcomes of Venus P valve for dysfunctional right ventricular outflow tract, and more!
Complex diagnosis
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].
Multivalvular disease: mitral and aortic valve challenges explored
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore cutting-edge transcatheter valve interventions for mitral and aortic valve disorders, including valve-in-valve procedures and management strategies for paravalvular leakages, and learn about diagnosing and treating mitral annular calcification and transcatheter options in infective endocarditis.
Mitral valve interventions for complex anatomy
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session on to learn more about how to manage complex anatomy and complications during mitral valve interventions. Discover compelling cases such as a valve-in-ring TMVR in a fluoroscopically invisible ring, PASCAL for bailout of MitraClip single-leaflet device attachment, and more!
Rapid-fire - Complex procedure in TAVI - Part 1
17 Feb 2024 – From PCR Tokyo Valves 2024
In the first part of this rapid-fire session, we focus on complex cases that might arise during TAVI, such as how to navigate a permanent pacemaker implantation, TAVI in a post-liver transplant patient with severe aortic regurgitation, or complex TAVI by transcarotid access.
Rapid-fire - Complications of Mitral TEER - Part 1
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases. Learn about what might cause a loud rumbling sound after intervention, and explore a rare complication of the MitraClip procedure.
How to optimise lifetime management of TAVI patients with long life expectancy?
17 Feb 2024 – From PCR Tokyo Valves 2024
In this special session sponsored by Abbott, gain insight into how valve design and features may influence clinical outcomes and future interventions. Learn about hemodynamic efficiency of TAVI valves, and understand the factors influencing durability and clinical performance over time.
TAVI in challenging anatomies
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to learn more about how to manage complex anatomy and complications during TAVI. Learn about successful cases of PTMC and TAVI performed simultaneously, gain insight into TAVI considerations and techniques for a very severely calcified aortic valve, and explore a scientific and safe...
Rapid-fire - Other SHD interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Structural heart disease might present unusual complications during intervention. In this series of rapid-fire case submissions, learn about intervention on a pregnant patient, complete heart block post TAVR, and TAVR on a nonagerian female.
Managing aortic stenosis in patients with longer life expectancy
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to understand what knowledge is needed for discussions with patients concerning lifetime management of valve disease, gain insight into the importance of predictable and precise commissural and coronary alignment for lifetime management, and learn about the indication of TAV-in-TAV and THV explant.
Tricuspid valve interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to understand T-TEER/TTVR procedure, learn about clinical indication and appropriate patient selection for TEER/TTVR based on TRILUMINATE trial/TRISCEND study, and update your knowledge of current transcatheter technologies for tricuspid regurgitation.
Rapid-fire - Bailout in SHD
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the bailout techniques in structural heart disease intervention in this session of rapid-fire submission cases (in Japanese).
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
The impact of COVID-19 pandemic on interventional cardiologists in training
23 Oct 2020
In collaboration with EuroIntervention Journal
The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...
ACC 2019 Day 1: PARTNER 3, Evolut Low Risk Trial and Apple Heart Study
17 Mar 2019
Mirvat Al Asnag reports live on three late-breaking trials presented at ACC 2019: PARTNER 3, Evolut Low Risk Trial and the Apple Heart Study
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.
Author
